Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis

National Medical Journal of China

Volumn 89, Issue 47, 2009, Pages 3341-3345

  Zhang, Rong ^a   Song, Yan ^a   Gao, Wei Jiao ^a   Zhang, Xun ^a   Zuo, Jing ^a   Lei, Cheng Zhi ^a   Wang, Ye ^a  

^a CANCER HOSPITAL   (China)

Author keywords

CD44V6; Cervix neoplasms; COX2; P53; Prognosis

Indexed keywords

CD44V6 ANTIGEN; CYCLOOXYGENASE 2; HERMES ANTIGEN; PROTEIN P53; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR EMBOLISM; UTERINE CERVIX TUMOR;

ADULT; AGED; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84871451031     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.47.010     Document Type: Article

References (11)

1. Rutledge TL, Kamelle SA, Tillmanns TD, et al. A comparison of stages I B1 and I B2 cervical cancers treated with radical hysterectomy. Is size the real difference? Gynecol Oncol, 2004, 95: 70-76.
2. Kim JH, Kim HJ, Hong S, et al. Post-hysterectomy radiotherapy in FIGO stage I B-II B uterine cervical carcinoma. Gynecol Oncol, 2005, 96: 407-414.
3. Wright JD, Grigsby PW, Brooks R, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer, 2007, 110: 1281-1286.
4. Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage I B and II A cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cance, 2000, 10: 305-312.
5. Juretzka MM, Jensen KC, Longacre TA, et al. Detection of pelvic lymph node micrometastasis in stage I A2-I B2 cervical cancer by immunohistochemical analysis. Gynecol Oncol, 2004, 93: 107-111.
6. Elliott P, Coppleson M, Russell P, et al. Early invasive (FIGO stage I A) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer, 2000, 10: 42-52.
7. Ayhan A, Al RA, Baykal C, et al. Prognostic factors in FIGO stage I B cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int J Gynecol Cancer, 2004, 14: 286-292.
8. Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol, 2004, 92: 525-529.
9. Oka K, Suzuki Y, Nakano T. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis. Cancer, 2000, 88: 2766-2773.
10. Bahnassy AA, Zekri AR, Madbouly MS, et al. The correlation between FHIT, P53 and MMR genes in human papillomavirus-associated cervical carcinoma. J Egypt Natl Canc Inst, 2006, 18: 191-202.
11. Ryu HS, Chang KH, Yang HW, et al. High cyclooxygenase-2 expression in stage I B cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol, 2000, 76: 320-325.